• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cadence Pharmaceuticals

Cadence Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Mallinckrodt Announces Key Leadership Appointments Following Completion of Questcor Acquisition

    Mallinckrodt Announces Key Leadership Appointments Following Completion of Questcor Acquisition

  2. Mallinckrodt Now a Component of the S&P 500 Index

    Mallinckrodt Now a Component of the S&P 500 Index

  3. Mallinckrodt Receives Patent from U.S. Patent and Trademark Office

    Mallinckrodt Receives Patent from U.S. Patent and Trademark Office

  4. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

    As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.